Psiron, psx has announced a $ 5 million funding package
shares on issue 62,500,000 market cap $ 3,000,000
-Developed a dermatology treatment for Psoriasis -New generation drug inhalation device based on inkjet (vapotronics) -Majority shareholder in Analytica Ltd , a company specializing in diagnostics - Cbio, a company developing a treatment for auto-immune disorders based on chaperonin-10
website www.psiron.com
the market seems to be rerating this small cap biotech now.
Good trading Ytrade
PSX Price at posting:
0.0¢ Sentiment: ST Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
